1.
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir
; 30(3): 225-30, 1981.
Artigo
em Romano
| MEDLINE
| ID: mdl-6115456
RESUMO
The paper presents the author's experience in post-anesthetic decurarization with a new antagonist of competitive curare. Presented for the first time in 1970, 4-amino-pyridine was found o tbe a substance with a different mode of action than that of reversible inhibitors of cholinesterase, without parasympaticomimetic effects, and without untoward effects on the cardio-circulatory function. It also has a central analeptic effect. This is why the authors consider the new drug as a powerful means for reversing the competitive neuromuscular blockage.